Journal article icon

Journal article

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population.

Abstract:

AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with features of the metabolic syndrome (MetS) and may be an expression of the syndrome within the liver. Using screening data from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) study (n = 42 149), we examined whether alanine aminotransferase (ALT), a biomarker for NAFLD, clustered with features of MetS and whether the clusters differed across global geographic regions. METHODS: Explorat...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Diabetic medicine : a journal of the British Diabetic Association
Volume:
26
Issue:
12
Pages:
1204-1211
Publication date:
2009-12-05
DOI:
EISSN:
1464-5491
ISSN:
0742-3071
URN:
uuid:fa081940-4988-4ca3-9247-4697b26dcc6b
Source identifiers:
244760
Local pid:
pubs:244760

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP